Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk ‘Long-acting therapies are no longer the future of HIV treatment – they are the now’ Is it COVID-19, flu, or RSV? The symptoms to look out for – and how to tell the diff...
Tony Wood, Chief Scientific Officer, GSK,said: “Our goal is to provide a high level of protection for older adults most at risk from RSV. These data show the efficacy of a single dose of our vaccine over two RSV seasons against RSV-...
Strong pipeline progress, with 4 major product approvals: Arexvy RSV vaccine; Apretude for HIV prevention; Ojjaara for myelofibrosis and Jemperli in 1L endometrial cancer Targeted business development further strengthens the pipeline including: acquisition of Bellus Health and proposed acquisition ...
在辉瑞任职期间,Dormitzer 负责监督其母体免疫(GSK3888550A)和老年人(GSK3844766A)的呼吸道合胞病毒(RSV)候选疫苗的开发,这些候选疫苗目前均处于 III 期临床试验阶段。Dormitzer 在 RSV 疫苗方面的开发经验将为葛兰素史克带来新的力量。 此外,Dormitzer 还负责辉瑞与 BioNTech 合作开发的基于 RNA 的流感疫苗候选药物。
在辉瑞任职期间,Dormitzer 负责监督其母体免疫(GSK3888550A)和老年人(GSK3844766A)的呼吸道合胞病毒(RSV)候选疫苗的开发,这些候选疫苗目前均处于 III 期临床试验阶段。Dormitzer 在 RSV 疫苗方面的开发经验将为葛兰素史克带来新的力量。 此外,Dormitzer 还负责辉瑞与 BioNTech 合作开发的基于 RNA的流感疫苗候选药物...
PRESS RELEASE Pfizer, GSK prep for battle in the world`s first RSV vax market 03 Nov 2022 // FIERCEPHARMA Seven pharma CEOs announce new joint action to accelerate net zero healthcare 03 Nov 2022 // BUSINESSWIRE Drugmaker GSK profit rockets on consumer health spinoff ...
Thanks James. But I'm not going to make too many comments on the announcement of Pfizer. But let me just highlight a few things about what we know about our project and why we're so excited about it. First of all, just to anchor everyone, of course RSV in older adults is an enor...
目前,已经有两款呼吸道合胞病毒(RSV)获得了美国FDA的,这标志着RSV防治领域的重大进展,完成了近60年来RSV疫苗开发的“零的突破”,填补了此前预防RSV病毒的疗法空白。这些成果源于对RSV病毒核心表面蛋白深度研究的革新性突破。 尽管成果斐然,鉴于RSV感染仍为全球重大的公共卫生难题,因此医药行业仍在抓紧开发新的RSV疫苗...
在辉瑞任职期间,Dormitzer 负责监督其母体免疫(GSK3888550A)和老年人(GSK3844766A)的呼吸道合胞病毒(RSV)候选疫苗的开发,这些候选疫苗目前均处于 III 期临床试验阶段。Dormitzer 在 RSV 疫苗方面的开发经验将为葛兰素史克带来新的力量。 此外,Dormitzer 还负责辉瑞与 BioNTech 合作开发的基于 RNA 的流感疫苗候选药...
另外,GSK 正在全球范围内开展呼吸道合胞病毒(RSV)疫苗的临床试验,同时也在研发流感疫苗。 在辉瑞任职期间,Dormitzer 负责监督其母体免疫(GSK3888550A)和老年人(GSK3844766A)的呼吸道合胞病毒(RSV)候选疫苗的开发,这些候选疫苗目前均处于 III 期临床试验阶段。Dormitzer 在 RSV 疫苗方面的开发经验将为葛兰素史克带...